A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of Spondias mombin L. to a patient. A medicament as described herein may comprise a pharmaceutically acceptable vehicle and a therapeutically effective amount of an extract of Spondias mombin L. suspended in the vehicle. A method of making an extract of Spondias mombin L. may comprise creating a component solution by treating Spondias mombin L. material with an extractor and a solvent and producing an extract by at least partially removing liquid from the component solution. An extract of Spondias mombin L. may comprise components extracted using various solvents.

 
Web www.patentalert.com

< USE OF DNA-PK INHIBITION TO SENSITISE ATM DEFICIENT CANCERS TO DNA-DAMAGING CANCER THERAPIES

> Novel reference plant, a method for its production, extracts obtained therefrom and their use

~ 00496